Physician profile
Jordan Nester
NPI 1689106270
$35,500.13
in general payments reported to CMS, 2019-2025
21 companies · $5,124 in 2025
The $5,124 reported for 2025 was more than what 82% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,105 · 2020: $213 · 2021: $4,257 · 2022: $22K · 2023: $2,193 · 2024: $448 · 2025: $5,124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,261 · Food and Beverage: $3,504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,261.02 |
| Food and Beverage | $3,503.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $23,503.56 | 2022-2025 | |
| Novus Surgical Solutions LLC | $3,669.80 | 2021 | |
| Stryker Corporation | $2,437.93 | 2019-2025 | Gamma, Pangea, Crossfire |
| Zak Ortho | $2,218.31 | 2024-2025 | |
| Alon Medical Technology | $1,300.20 | 2022 | |
| Smith+Nephew, INC. | $414.42 | 2022-2023 | Healicoil, Bioinductive Implant With Arthroscopic Delivery System - Medium, Q-Fix |
| Lightbody Medical Technologies INC | $317.96 | 2024 | |
| Acumed LLC | $293.17 | 2021-2023 | Acumed |
| Depuy Synthes Sales INC. | $267.01 | 2023 | |
| Medwest Associates | $184.29 | 2023 | |
| Medacta USA, INC. | $158.79 | 2021 | |
| US Implant Solutions, LLC | $138.04 | 2025 | |
| Vericel Corporation | $124.01 | 2023 | Maci |
| Lifenet Health | $122.85 | 2022 | |
| Zimmer Biomet Holdings, INC. | $108.92 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $86.87 | 2021 | |
| Bioventus LLC | $51.66 | 2024 | Exogen Ultrasound Bone Healing System, Durolane |
| Janssen Biotech, INC. | $32.28 | 2024 | Erleada |
| Nuvasive, INC. | $30.06 | 2019 | |
| Linvatec Corporation | $25.11 | 2023 | Biobrace 23mm |
| Ferring Pharmaceuticals INC. | $14.89 | 2023 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Nester listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.